Concepedia

Fabian Eggimann

FE

Statistics

Publications

8

Citations

333

H-Index

8

Active since

2014

Affiliations

Novartis (Switzerland)(Current)

Graz University of Technology

Novartis (United States)

Institute of Molecular Biotechnology

Novartis Institutes for BioMedical Research

Fabian Eggimann is an author at Novartis (Switzerland) specializing in biocatalysis, biosynthesis, and metabolic engineering.

Top concepts

Publications per year

2014–2021

8

Publications

8

Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases

A. S. Nagle, Agnes Biggart, C. Be et al. · Journal of Medicinal Chemistry · 2020 · 111 citations · Full text

Machine-Directed Evolution of an Imine Reductase for Activity and Stereoselectivity

J Gilbert Eric, Elina Siirola, Charles M. Moore et al. · ACS Catalysis · 2021 · 95 citations

, , +18

Disposition of asciminib, a potent BCR-ABL1 tyrosine kinase inhibitor, in healthy male subjects

Phi Tran, Imad Hanna, Fabian Eggimann et al. · Xenobiotica · 2019 · 27 citations · Full text

Human FMO2-based microbial whole-cell catalysts for drug metabolite synthesis

Martina Geier, Thorsten Bachler, Steven P. Hanlon et al. · Microbial Cell Factories · 2015 · 24 citations · Full text

CYP27A1-dependent anti-melanoma activity of limonoid natural products targets mitochondrial metabolism

Hyelim Cho, Qiong Shen, Lydia H. Zhang et al. · Cell chemical biology · 2021 · 23 citations · Full text

, , +5

1–5 of 8